| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Box Domain Proteins | 15 | 2021 | 118 | 5.360 |
Why?
|
| Heart | 20 | 2023 | 539 | 2.960 |
Why?
|
| Gene Regulatory Networks | 11 | 2024 | 296 | 2.720 |
Why?
|
| Hedgehog Proteins | 12 | 2022 | 93 | 2.520 |
Why?
|
| Transcription Factors | 15 | 2024 | 1565 | 2.100 |
Why?
|
| Atrial Fibrillation | 7 | 2024 | 288 | 1.970 |
Why?
|
| Transcription, Genetic | 8 | 2021 | 1135 | 1.970 |
Why?
|
| Enhancer Elements, Genetic | 8 | 2020 | 266 | 1.640 |
Why?
|
| Gene Expression Regulation, Developmental | 16 | 2023 | 623 | 1.570 |
Why?
|
| Mice | 52 | 2024 | 11352 | 1.450 |
Why?
|
| Homeodomain Proteins | 9 | 2023 | 536 | 1.420 |
Why?
|
| Atrioventricular Node | 5 | 2020 | 33 | 1.410 |
Why?
|
| Heart Septal Defects | 4 | 2020 | 31 | 1.410 |
Why?
|
| Myocytes, Cardiac | 15 | 2023 | 275 | 1.390 |
Why?
|
| Zinc Finger Protein GLI1 | 4 | 2022 | 19 | 1.270 |
Why?
|
| Heart Conduction System | 9 | 2012 | 108 | 1.220 |
Why?
|
| Heart Defects, Congenital | 9 | 2016 | 351 | 1.140 |
Why?
|
| Animals | 65 | 2024 | 26582 | 1.130 |
Why?
|
| Signal Transduction | 17 | 2022 | 3241 | 1.110 |
Why?
|
| Myocardium | 14 | 2017 | 529 | 1.040 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2022 | 187 | 1.020 |
Why?
|
| GATA4 Transcription Factor | 4 | 2024 | 17 | 0.960 |
Why?
|
| Atrial Remodeling | 1 | 2024 | 17 | 0.960 |
Why?
|
| Mutation | 19 | 2020 | 3968 | 0.940 |
Why?
|
| Heart Ventricles | 5 | 2020 | 760 | 0.850 |
Why?
|
| Gene Expression Regulation | 9 | 2021 | 1920 | 0.820 |
Why?
|
| Calcium Signaling | 2 | 2019 | 129 | 0.810 |
Why?
|
| RNA, Untranslated | 2 | 2020 | 63 | 0.800 |
Why?
|
| Calcium | 3 | 2024 | 1156 | 0.800 |
Why?
|
| Heart Rate | 4 | 2020 | 492 | 0.800 |
Why?
|
| Body Patterning | 5 | 2020 | 209 | 0.780 |
Why?
|
| Cell Nucleus | 2 | 2020 | 579 | 0.780 |
Why?
|
| Cilia | 3 | 2016 | 29 | 0.770 |
Why?
|
| Fibroblast Growth Factor 4 | 1 | 2020 | 6 | 0.760 |
Why?
|
| Gastrulation | 1 | 2020 | 14 | 0.750 |
Why?
|
| Progeria | 1 | 2020 | 5 | 0.750 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2020 | 28 | 0.750 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2023 | 148 | 0.740 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2020 | 9 | 0.740 |
Why?
|
| Lamin Type A | 1 | 2020 | 24 | 0.730 |
Why?
|
| Mice, Transgenic | 16 | 2023 | 1540 | 0.730 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2019 | 24 | 0.730 |
Why?
|
| Genetic Loci | 3 | 2020 | 250 | 0.720 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2020 | 41 | 0.720 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2020 | 42 | 0.710 |
Why?
|
| Wnt2 Protein | 1 | 2018 | 6 | 0.680 |
Why?
|
| Eye Proteins | 1 | 2020 | 128 | 0.670 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 3 | 2022 | 31 | 0.650 |
Why?
|
| Lung | 3 | 2021 | 1170 | 0.610 |
Why?
|
| Homeostasis | 1 | 2019 | 409 | 0.610 |
Why?
|
| Mice, Knockout | 11 | 2021 | 1924 | 0.610 |
Why?
|
| Heart Failure | 4 | 2024 | 1204 | 0.600 |
Why?
|
| Axonemal Dyneins | 1 | 2016 | 5 | 0.580 |
Why?
|
| Regulon | 1 | 2015 | 16 | 0.540 |
Why?
|
| Heart Atria | 3 | 2024 | 250 | 0.540 |
Why?
|
| Disease Models, Animal | 11 | 2019 | 2232 | 0.530 |
Why?
|
| Heart Diseases | 2 | 2015 | 290 | 0.520 |
Why?
|
| Genome-Wide Association Study | 9 | 2023 | 1621 | 0.510 |
Why?
|
| Genetic Variation | 3 | 2018 | 1351 | 0.500 |
Why?
|
| Transcriptome | 5 | 2022 | 580 | 0.490 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2014 | 6 | 0.490 |
Why?
|
| Heart Septum | 2 | 2017 | 45 | 0.470 |
Why?
|
| Cell Lineage | 4 | 2022 | 273 | 0.470 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 166 | 0.470 |
Why?
|
| Chromatin | 5 | 2023 | 380 | 0.460 |
Why?
|
| Recombination, Genetic | 3 | 2011 | 439 | 0.450 |
Why?
|
| Cell Proliferation | 10 | 2021 | 1578 | 0.440 |
Why?
|
| Potassium Channels, Voltage-Gated | 3 | 2020 | 122 | 0.440 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 813 | 0.430 |
Why?
|
| Haploinsufficiency | 4 | 2019 | 62 | 0.420 |
Why?
|
| Humans | 46 | 2024 | 86643 | 0.420 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2011 | 30 | 0.410 |
Why?
|
| Proteins | 2 | 2016 | 777 | 0.410 |
Why?
|
| Sodium Channels | 1 | 2012 | 129 | 0.400 |
Why?
|
| Integrases | 1 | 2011 | 59 | 0.400 |
Why?
|
| Limb Deformities, Congenital | 1 | 2011 | 21 | 0.400 |
Why?
|
| Cell Differentiation | 7 | 2023 | 1458 | 0.400 |
Why?
|
| Heart Valves | 1 | 2011 | 13 | 0.400 |
Why?
|
| Smad4 Protein | 1 | 2011 | 23 | 0.400 |
Why?
|
| Promoter Regions, Genetic | 6 | 2018 | 937 | 0.390 |
Why?
|
| Embryo, Mammalian | 7 | 2019 | 207 | 0.390 |
Why?
|
| Hydrocephalus | 1 | 2011 | 101 | 0.370 |
Why?
|
| Single-Cell Analysis | 2 | 2022 | 134 | 0.360 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2011 | 379 | 0.360 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2023 | 104 | 0.360 |
Why?
|
| Atrial Septum | 1 | 2009 | 9 | 0.350 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2016 | 64 | 0.340 |
Why?
|
| Genomics | 4 | 2024 | 720 | 0.340 |
Why?
|
| Down Syndrome | 2 | 2020 | 53 | 0.320 |
Why?
|
| Cell Line | 5 | 2020 | 2468 | 0.310 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2007 | 15 | 0.310 |
Why?
|
| Abnormalities, Multiple | 3 | 2016 | 232 | 0.310 |
Why?
|
| Mesoderm | 4 | 2022 | 108 | 0.290 |
Why?
|
| Cytoskeletal Proteins | 3 | 2020 | 223 | 0.290 |
Why?
|
| Action Potentials | 2 | 2020 | 573 | 0.290 |
Why?
|
| Helminth Proteins | 2 | 1996 | 12 | 0.280 |
Why?
|
| Zygote | 2 | 2015 | 40 | 0.270 |
Why?
|
| Caenorhabditis elegans Proteins | 3 | 2005 | 109 | 0.260 |
Why?
|
| Lower Extremity Deformities, Congenital | 2 | 2016 | 4 | 0.260 |
Why?
|
| Upper Extremity Deformities, Congenital | 2 | 2016 | 5 | 0.260 |
Why?
|
| Gastrula | 2 | 2022 | 27 | 0.240 |
Why?
|
| Neural Crest | 2 | 2022 | 25 | 0.240 |
Why?
|
| Binding Sites | 2 | 2020 | 1098 | 0.240 |
Why?
|
| Homeobox Protein Nkx-2.5 | 6 | 2023 | 12 | 0.240 |
Why?
|
| Electrocardiography | 7 | 2012 | 478 | 0.240 |
Why?
|
| Receptors, Notch | 4 | 2020 | 120 | 0.230 |
Why?
|
| Male | 18 | 2020 | 40965 | 0.230 |
Why?
|
| Myocardial Contraction | 2 | 2016 | 244 | 0.230 |
Why?
|
| Brugada Syndrome | 1 | 2022 | 14 | 0.230 |
Why?
|
| Caenorhabditis elegans | 4 | 2005 | 223 | 0.220 |
Why?
|
| Embryonic Development | 2 | 2009 | 74 | 0.220 |
Why?
|
| Stem Cells | 4 | 2017 | 351 | 0.220 |
Why?
|
| Mice, Mutant Strains | 4 | 2018 | 229 | 0.210 |
Why?
|
| Connexins | 4 | 2020 | 200 | 0.210 |
Why?
|
| Retinal Dehydrogenase | 1 | 2021 | 6 | 0.210 |
Why?
|
| Xenopus Proteins | 1 | 2021 | 34 | 0.210 |
Why?
|
| NFATC Transcription Factors | 1 | 2021 | 29 | 0.210 |
Why?
|
| Response Elements | 1 | 2021 | 63 | 0.200 |
Why?
|
| Xenopus | 1 | 2021 | 125 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2023 | 292 | 0.200 |
Why?
|
| Receptor, Notch4 | 1 | 2020 | 5 | 0.200 |
Why?
|
| Cells, Cultured | 4 | 2020 | 2818 | 0.190 |
Why?
|
| GATA6 Transcription Factor | 2 | 2019 | 13 | 0.190 |
Why?
|
| Cell Communication | 2 | 2006 | 194 | 0.190 |
Why?
|
| Female | 17 | 2020 | 44532 | 0.180 |
Why?
|
| Chick Embryo | 1 | 2020 | 229 | 0.180 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2020 | 70 | 0.180 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2020 | 75 | 0.180 |
Why?
|
| Mutagenesis | 2 | 2011 | 199 | 0.180 |
Why?
|
| Fibroblast Growth Factors | 1 | 2020 | 80 | 0.180 |
Why?
|
| Smoothened Receptor | 1 | 2019 | 6 | 0.180 |
Why?
|
| Ventricular Septum | 1 | 2019 | 11 | 0.180 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 21 | 0.170 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2019 | 21 | 0.170 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1999 | 6 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 3092 | 0.170 |
Why?
|
| Salamandridae | 1 | 2018 | 2 | 0.170 |
Why?
|
| Mutant Proteins | 1 | 2019 | 94 | 0.170 |
Why?
|
| Fibroblasts | 2 | 2020 | 729 | 0.170 |
Why?
|
| Ethylnitrosourea | 2 | 2016 | 30 | 0.170 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 36 | 0.170 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 325 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2018 | 100 | 0.160 |
Why?
|
| Morphogenesis | 4 | 2022 | 192 | 0.160 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2018 | 93 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 217 | 0.160 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 1384 | 0.160 |
Why?
|
| Zebrafish | 2 | 2018 | 309 | 0.160 |
Why?
|
| HEK293 Cells | 1 | 2020 | 615 | 0.160 |
Why?
|
| Cyclosporine | 1 | 1999 | 234 | 0.160 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 388 | 0.160 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 397 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 2271 | 0.150 |
Why?
|
| Sumoylation | 3 | 2011 | 18 | 0.150 |
Why?
|
| Regeneration | 1 | 2018 | 143 | 0.150 |
Why?
|
| Membrane Glycoproteins | 3 | 2005 | 428 | 0.150 |
Why?
|
| Endothelial Cells | 2 | 2018 | 428 | 0.150 |
Why?
|
| Periodicity | 1 | 2017 | 119 | 0.150 |
Why?
|
| Embryonic Induction | 1 | 1996 | 17 | 0.150 |
Why?
|
| Trans-Activators | 1 | 2020 | 429 | 0.150 |
Why?
|
| Atrial Function | 1 | 2016 | 17 | 0.150 |
Why?
|
| Protein Binding | 1 | 2020 | 1456 | 0.140 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 102 | 0.140 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 479 | 0.140 |
Why?
|
| RNA | 1 | 2020 | 560 | 0.140 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 69 | 0.140 |
Why?
|
| Exome | 1 | 2016 | 127 | 0.130 |
Why?
|
| Biomarkers | 2 | 2020 | 1718 | 0.130 |
Why?
|
| Trisomy | 1 | 2015 | 55 | 0.130 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2008 | 42 | 0.130 |
Why?
|
| Pedigree | 3 | 2016 | 966 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 1996 | 286 | 0.130 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2015 | 13 | 0.130 |
Why?
|
| Zinc Finger Protein Gli3 | 1 | 2014 | 8 | 0.130 |
Why?
|
| Blastomeres | 1 | 1994 | 7 | 0.130 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 35 | 0.130 |
Why?
|
| Mice, Inbred C3H | 2 | 2015 | 370 | 0.130 |
Why?
|
| Aortic Valve | 2 | 2015 | 222 | 0.130 |
Why?
|
| SUMO-1 Protein | 2 | 2011 | 16 | 0.130 |
Why?
|
| DNA Nucleotidyltransferases | 2 | 1991 | 32 | 0.130 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2015 | 38 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 456 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 350 | 0.120 |
Why?
|
| Brain Ischemia | 1 | 2018 | 398 | 0.120 |
Why?
|
| Alleles | 3 | 2018 | 1128 | 0.120 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 109 | 0.120 |
Why?
|
| Organogenesis | 2 | 2016 | 41 | 0.120 |
Why?
|
| DNA, Bacterial | 2 | 1991 | 236 | 0.120 |
Why?
|
| Wolff-Parkinson-White Syndrome | 2 | 2003 | 11 | 0.120 |
Why?
|
| Sarcomeres | 3 | 2009 | 23 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2020 | 1981 | 0.120 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2018 | 45 | 0.120 |
Why?
|
| Multienzyme Complexes | 2 | 2003 | 64 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 1999 | 977 | 0.120 |
Why?
|
| Genome, Human | 1 | 2018 | 756 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2018 | 2357 | 0.110 |
Why?
|
| Endothelium | 2 | 2023 | 59 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 246 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2011 | 302 | 0.110 |
Why?
|
| Transgenes | 3 | 2011 | 180 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2012 | 695 | 0.110 |
Why?
|
| Escherichia coli | 3 | 2011 | 597 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 77 | 0.110 |
Why?
|
| Adolescent | 3 | 2020 | 8981 | 0.110 |
Why?
|
| Time Factors | 2 | 2020 | 5210 | 0.100 |
Why?
|
| Risk Factors | 2 | 2019 | 5417 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2015 | 403 | 0.100 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2011 | 97 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 133 | 0.100 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2011 | 4 | 0.100 |
Why?
|
| Cysteine Endopeptidases | 1 | 2011 | 87 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 503 | 0.100 |
Why?
|
| Base Sequence | 5 | 2021 | 2330 | 0.100 |
Why?
|
| Arteries | 1 | 2012 | 176 | 0.100 |
Why?
|
| Phenotype | 6 | 2022 | 2378 | 0.100 |
Why?
|
| Child | 3 | 2020 | 6927 | 0.100 |
Why?
|
| Bundle of His | 1 | 2011 | 42 | 0.100 |
Why?
|
| Staining and Labeling | 1 | 2011 | 165 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 827 | 0.100 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2011 | 67 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2011 | 268 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2011 | 70 | 0.100 |
Why?
|
| Esophagus | 1 | 2011 | 102 | 0.100 |
Why?
|
| Spine | 1 | 2011 | 102 | 0.090 |
Why?
|
| Anal Canal | 1 | 2011 | 89 | 0.090 |
Why?
|
| Tamoxifen | 1 | 2011 | 168 | 0.090 |
Why?
|
| Lac Operon | 2 | 2007 | 46 | 0.090 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 126 | 0.090 |
Why?
|
| Mediastinal Neoplasms | 1 | 2010 | 46 | 0.090 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2010 | 55 | 0.090 |
Why?
|
| Trachea | 1 | 2011 | 293 | 0.090 |
Why?
|
| Cardiomyopathies | 2 | 2003 | 240 | 0.090 |
Why?
|
| Protein Transport | 1 | 2011 | 411 | 0.090 |
Why?
|
| Myosin Heavy Chains | 3 | 2020 | 88 | 0.090 |
Why?
|
| Stroke | 1 | 2018 | 965 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 279 | 0.090 |
Why?
|
| E2F3 Transcription Factor | 1 | 2008 | 2 | 0.090 |
Why?
|
| Chromosome Mapping | 2 | 2010 | 1074 | 0.090 |
Why?
|
| Genes, Lethal | 1 | 2009 | 53 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2008 | 4 | 0.090 |
Why?
|
| Carrier Proteins | 4 | 2011 | 673 | 0.090 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2009 | 73 | 0.090 |
Why?
|
| Heterozygote | 3 | 2019 | 365 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 301 | 0.080 |
Why?
|
| Lymphoma | 1 | 2010 | 262 | 0.080 |
Why?
|
| Ventricular Fibrillation | 1 | 2008 | 65 | 0.080 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2008 | 67 | 0.080 |
Why?
|
| Troponin T | 1 | 2008 | 37 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2020 | 2379 | 0.080 |
Why?
|
| Sinoatrial Node | 1 | 2007 | 10 | 0.080 |
Why?
|
| Pregnancy | 1 | 2014 | 2894 | 0.070 |
Why?
|
| Homozygote | 3 | 2016 | 200 | 0.070 |
Why?
|
| Contractile Proteins | 1 | 2006 | 54 | 0.070 |
Why?
|
| Models, Biological | 4 | 2015 | 1749 | 0.070 |
Why?
|
| Tetralogy of Fallot | 1 | 2006 | 44 | 0.070 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2005 | 45 | 0.070 |
Why?
|
| Cell Fusion | 1 | 2005 | 39 | 0.070 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2005 | 19 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 208 | 0.070 |
Why?
|
| Kidney | 1 | 2011 | 1241 | 0.060 |
Why?
|
| Mutation, Missense | 2 | 2003 | 276 | 0.060 |
Why?
|
| Aortic Valve Stenosis | 1 | 2006 | 131 | 0.060 |
Why?
|
| Truncus Arteriosus | 2 | 2019 | 3 | 0.060 |
Why?
|
| Laser Therapy | 2 | 1996 | 142 | 0.060 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2003 | 3 | 0.060 |
Why?
|
| Bradycardia | 1 | 2003 | 39 | 0.060 |
Why?
|
| Glycogen Storage Disease | 1 | 2003 | 5 | 0.060 |
Why?
|
| Ventricular Dysfunction | 1 | 2003 | 28 | 0.060 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2022 | 19 | 0.060 |
Why?
|
| Cardiomegaly | 1 | 2003 | 111 | 0.060 |
Why?
|
| Electrophysiology | 4 | 2005 | 401 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 123 | 0.050 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2002 | 2 | 0.050 |
Why?
|
| Computational Biology | 2 | 2020 | 528 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 262 | 0.050 |
Why?
|
| Sodium | 1 | 2022 | 341 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2015 | 510 | 0.050 |
Why?
|
| Genetic Markers | 1 | 2022 | 476 | 0.050 |
Why?
|
| Myocarditis | 1 | 2002 | 50 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2021 | 137 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2021 | 351 | 0.050 |
Why?
|
| Cell Movement | 2 | 2019 | 758 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 76 | 0.050 |
Why?
|
| Connexin 43 | 1 | 2020 | 94 | 0.040 |
Why?
|
| Infant | 2 | 2020 | 3046 | 0.040 |
Why?
|
| Cardiac Myosins | 2 | 2009 | 18 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 2019 | 39 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 674 | 0.040 |
Why?
|
| Platelet Count | 1 | 1999 | 92 | 0.040 |
Why?
|
| Gene Expression | 2 | 2011 | 1284 | 0.040 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 3 | 2003 | 39 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 3030 | 0.040 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2018 | 21 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2008 | 2207 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 197 | 0.040 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 77 | 0.040 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 71 | 0.040 |
Why?
|
| Workflow | 1 | 2018 | 77 | 0.040 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1996 | 9 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 1208 | 0.040 |
Why?
|
| Adult | 2 | 2014 | 25648 | 0.040 |
Why?
|
| Chemokine CCL4 | 1 | 1996 | 9 | 0.040 |
Why?
|
| Models, Animal | 1 | 2018 | 263 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 1996 | 34 | 0.040 |
Why?
|
| Chimera | 1 | 1996 | 56 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 304 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2008 | 293 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 853 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 55 | 0.030 |
Why?
|
| Ligands | 1 | 1996 | 433 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2015 | 3612 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2015 | 33 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2018 | 710 | 0.030 |
Why?
|
| DNA, Recombinant | 2 | 1991 | 67 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2017 | 502 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2015 | 207 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 115 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2015 | 111 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 172 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 179 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1994 | 316 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 1991 | 347 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 265 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2767 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 504 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2003 | 64 | 0.030 |
Why?
|
| Kinetics | 2 | 1991 | 1513 | 0.030 |
Why?
|
| DNA, Superhelical | 1 | 1991 | 16 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 181 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2705 | 0.030 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2011 | 12 | 0.030 |
Why?
|
| Cleft Lip | 1 | 2011 | 15 | 0.030 |
Why?
|
| Cleft Palate | 1 | 2011 | 25 | 0.020 |
Why?
|
| Point Mutation | 1 | 2012 | 246 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1991 | 135 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1991 | 229 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2011 | 93 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 439 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 171 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1996 | 1196 | 0.020 |
Why?
|
| Echocardiography | 2 | 2008 | 911 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2010 | 271 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2009 | 97 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2009 | 36 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 879 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2008 | 62 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2009 | 41 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 427 | 0.020 |
Why?
|
| Fibrosis | 1 | 2008 | 203 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2008 | 331 | 0.020 |
Why?
|
| Filamins | 1 | 2006 | 19 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2008 | 458 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 348 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2010 | 535 | 0.020 |
Why?
|
| Genome | 1 | 2009 | 372 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2005 | 68 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2010 | 628 | 0.020 |
Why?
|
| Genes, Helminth | 1 | 2005 | 7 | 0.020 |
Why?
|
| United States | 1 | 2018 | 6672 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 1991 | 864 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 1197 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2005 | 122 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1683 | 0.020 |
Why?
|
| Procainamide | 1 | 2003 | 4 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 72 | 0.010 |
Why?
|
| Endocardium | 1 | 2003 | 76 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2003 | 153 | 0.010 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2003 | 58 | 0.010 |
Why?
|
| Mortality | 1 | 2003 | 149 | 0.010 |
Why?
|
| Giant Cells | 1 | 2002 | 19 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2001 | 39 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2001 | 205 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 256 | 0.010 |
Why?
|
| Adenosine | 1 | 2003 | 225 | 0.010 |
Why?
|
| Family Health | 1 | 2001 | 162 | 0.010 |
Why?
|
| RNA Splicing | 1 | 2001 | 142 | 0.010 |
Why?
|
| Biopsy | 1 | 2003 | 1163 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 1863 | 0.010 |
Why?
|
| Disease Progression | 1 | 2003 | 1531 | 0.010 |
Why?
|
| Age Factors | 1 | 2003 | 1851 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 1851 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2001 | 318 | 0.010 |
Why?
|
| Actins | 1 | 2001 | 451 | 0.010 |
Why?
|
| Brain | 1 | 2006 | 2216 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2002 | 705 | 0.010 |
Why?
|
| Epidermis | 1 | 1994 | 100 | 0.010 |
Why?
|
| Hysteria | 1 | 1953 | 1 | 0.010 |
Why?
|
| Conversion Disorder | 1 | 1953 | 3 | 0.010 |
Why?
|
| Poliomyelitis | 1 | 1953 | 28 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1991 | 49 | 0.010 |
Why?
|
| Rec A Recombinases | 1 | 1991 | 14 | 0.010 |
Why?
|
| Plasmids | 1 | 1991 | 287 | 0.010 |
Why?
|
| Middle Aged | 1 | 2009 | 25028 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1991 | 332 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1953 | 1565 | 0.010 |
Why?
|